Feed NDATF
ND

nDatalyze Corp.

NDATF · OTC

$0.08 +0.00% (+$0.00)
Market Cap $4.56M
P/E Ratio -
Div. Yield -
ROE 62.42%

Bulios Fair Price

$0.05

37.5% downside

Current Price

$0.08

Undervalued Fair Value Overvalued

According to Bulios Fair Price, NDATF is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Weak
1/9
Valuation
0 /100
Expensive
P/B 21.97x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining
Book val. growth 17.28%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A
Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor
ROIC 113.13%
Asset turnover 0.00x
ROE 62.42%
Debt
69 /100
Low
Debt/Equity 0.00x
Int. coverage -72.37x
Current ratio 8.81x
Stability
8 /100
Unstable
Beta 0.07x
Profitable years 0
Rev. volatility 31.99%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about NDATF
Online

Sector

Healthcare

Industry

Medical - Healthcare Information Services

CEO

James Morris Durward

Employees

1

Headquarters

Calgary

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.